Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies

Plus: Panacea Exits Joint Venture

The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.  

Vaccines_Euros
Moderna is the fifth company the Commission has engaged in talks to provide vaccines for EU citizens.

The first participants have been dosed in a Phase I trial of AZD7442, AstraZeneca PLC’s combination of two monoclonal antibodies (mAbs) for the prevention and treatment of COVID-19.

The trial will evaluate the safety, tolerability and pharmacokinetics of the antibody cocktail in up to 48 healthy participants in...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip